Photo by Vitaly Gorbachev on Pexels
Tularemia Okuloglandular (A21.1): Penyebab, Gejala, Diagnosis, dan Penanganan
📚 Daftar Pustaka (APA 7)
[1]
Centers for Disease Control and Prevention. (2022). Tularemia: Clinical Features. Atlanta, GA: CDC.
[2]
World Health Organization. (2021). Tularemia - Fact Sheet. Geneva: WHO.
[3]
Ellis, J., Oyston, P. C., Green, M., & Titball, R. W. (2002). Tularemia. Clinical Microbiology Reviews, 15(4), 631-646.
[4]
Hepburn, M. J., & Simpson, A. J. (2008). Tularemia: Current Treatment Options. Expert Opinion on Pharmacotherapy, 9(5), 765-779.
[5]
Johansson, A., Berglund, L., Sjöstedt, A., & Tärnvik, A. (2001). Ciprofloxacin for Treatment of Tularemia. Clinical Infectious Diseases, 33(5), 722-723.
[6]
Petersen, J. M., & Schriefer, M. E. (2005). Tularemia: Emerging/Re-emerging Disease. Veterinary Microbiology, 107(3-4), 103-109.
[7]
Sjöstedt, A. B. (2007). Tularemia: Current Status and Future Perspectives. Future Microbiology, 2(4), 359-361.
[8]
World Health Organization. (2007). WHO Guidelines on Tularemia. Geneva: WHO Press.